IVUS strategic USD 1.1 billion market by 2030

The “Intravascular ultrasound (IVUS): Global strategic business report” report has been added to ResearchAndMarkets.com’s offering.

Global intravascular ultrasound (IVUS) market to Reach $1.1 Billion by 2030

The global market for intravascular ultrasound (IVUS) estimated at US$634.2 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030.

IVUS Catheters, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$659 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the IVUS Consoles segment is readjusted to a revised 6.7% CAGR for the next 8-year period.

The U.S. market is estimated at $231.6 Million, while China is forecast to Grow at 10.1% CAGR
The intravascular ultrasound (IVUS) market in the U.S. is estimated at US$231.6 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$137.9 Million by the year 2030.

Focus on select players (Total 15 featured)

• Boston Scientific Corporation
• InfraredxT, Inc.
• Koninklijke Philips N.V. (Royal Philips)
• Terumo Corp.

Research and Markets